peptide injections retatrutide Buy Sciences 20mg / $172 only Retatrutide 10mg UK | Research

JCI Insight 6 , e153732 (2021)

GLP-1 Receptor Agonist Market Trends Expansion of Oral GLP-1 Receptor Agonist Therapies Beyond Injectable Formulations The market is witnessing a transition from injectable-only treatment approaches toward oral GLP-1 receptor agonist therapies, improving patient convenience and treatment adherence

Scientists have long recognised the potential benefits of transdermal drug delivery, including improved patient compliance, steady drug release, and avoidance of gastrointestinal degradation and first-pass metabolism

This limits the affordability of many patients, especially from low- and middle-income groups and those who do not have medical insurance, restricting market growth